Accelerate Diagnostics Inc AXDX shares are trading lower by 23.2% to $2.84 Tuesday morning after the company announced the initiation of a proposed underwritten public offering of 4.5 million units.
Each unit comprises one share of common stock and one warrant to purchase one share of common stock. Alternatively, certain investors may opt for pre-funded units, which include one pre-funded warrant to purchase one share of common stock and one regular warrant.
The company anticipates granting the underwriters a 30-day option to acquire up to an additional 675,000 shares of common stock and/or additional warrants. The completion and specific terms of the offering are contingent on market and other conditions, with no guaranteed assurance of completion or final size.
According to data from Benzinga Pro, AXDX has a 52-week high of $11.90 and a 52-week low of $2.76.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.